Gui Zhao

1.1k total citations
28 papers, 697 citations indexed

About

Gui Zhao is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Gui Zhao has authored 28 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Gui Zhao's work include CAR-T cell therapy research (6 papers), RNA Interference and Gene Delivery (6 papers) and Immunotherapy and Immune Responses (5 papers). Gui Zhao is often cited by papers focused on CAR-T cell therapy research (6 papers), RNA Interference and Gene Delivery (6 papers) and Immunotherapy and Immune Responses (5 papers). Gui Zhao collaborates with scholars based in China, United States and Singapore. Gui Zhao's co-authors include Jun Wang, Cong‐Fei Xu, Ying‐Li Luo, Zi-Dong Lu, Song Shen, Zhiting Cao, Anna Czarna, Yue Zhang, Yue Zhang and Guojun Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Cancer Research.

In The Last Decade

Gui Zhao

27 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gui Zhao China 13 410 185 123 106 93 28 697
Xiandi Meng China 9 431 1.1× 116 0.6× 66 0.5× 104 1.0× 91 1.0× 18 600
Chun‐Wei Chi United States 9 320 0.8× 197 1.1× 64 0.5× 58 0.5× 28 0.3× 12 506
Tzu‐Chieh Ho United States 9 366 0.9× 79 0.4× 71 0.6× 89 0.8× 36 0.4× 16 559
Mohammed Fatih Rasul Iraq 12 552 1.3× 91 0.5× 146 1.2× 69 0.7× 110 1.2× 36 841
Jing Gong United States 12 587 1.4× 57 0.3× 83 0.7× 34 0.3× 46 0.5× 20 739
Lei Dang China 10 424 1.0× 79 0.4× 79 0.6× 32 0.3× 27 0.3× 14 574
Jilian R. Melamed United States 14 638 1.6× 175 0.9× 60 0.5× 121 1.1× 155 1.7× 22 884

Countries citing papers authored by Gui Zhao

Since Specialization
Citations

This map shows the geographic impact of Gui Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui Zhao more than expected).

Fields of papers citing papers by Gui Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui Zhao. The network helps show where Gui Zhao may publish in the future.

Co-authorship network of co-authors of Gui Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Gui Zhao. A scholar is included among the top collaborators of Gui Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui Zhao. Gui Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zhe, Rui Jin, Gui Zhao, et al.. (2025). Atomically dispersed Ru in ZIF-67 as a high-performance HER catalyst: in situ structural evolution and deactivation mechanism elucidation. Materials Horizons. 12(24). 10690–10697. 5 indexed citations
2.
Zhang, Yue, Gui Zhao, Jing Liu, et al.. (2023). Gene-activating nanomedicine for the tumor-oriented infiltration of T cells to enhance immunotherapy against solid tumors. Nano Today. 52. 101992–101992. 7 indexed citations
3.
Zhang, Yue, Gui Zhao, Yifang Chen, et al.. (2023). Engineering nano‐clustered multivalent agonists to cross‐link TNF receptors for cancer therapy. SHILAP Revista de lepidopterología. 4(6). 13 indexed citations
4.
Zhao, Gui, Yue Zhang, Cong‐Fei Xu, & Jun Wang. (2023). In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesicles. Science Bulletin. 69(3). 354–366. 31 indexed citations
5.
Qian, Weiping, Shu Xia, Xiaoyun Yang, et al.. (2022). Complex Involvement of the Extracellular Matrix, Immune Effect, and Lipid Metabolism in the Development of Idiopathic Pulmonary Fibrosis. Frontiers in Molecular Biosciences. 8. 800747–800747. 17 indexed citations
6.
Yang, Zehong, Qianhua Li, Dong-Hui Zheng, et al.. (2022). A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive Dermatomyositis. Frontiers in Medicine. 9. 860798–860798. 13 indexed citations
7.
Li, Yunan, Luozhen Jiang, Gui Zhao, et al.. (2022). Enhancing the low-temperature CO oxidation over Pt/Y2O3 catalyst: The effects of Pt dispersion and support basicity on the catalytic performance. Applied Surface Science. 614. 156210–156210. 4 indexed citations
9.
Zhao, Gui, et al.. (2021). Enrichment Characteristics, Occurrence and Origin of Valuable Trace Elements in Lignite from Linchang Coal Mine, Guangxi, China. Journal of Geoscience and Environment Protection. 9(12). 133–150. 4 indexed citations
10.
Luo, Ying‐Li, Lifang Liang, Jing Liu, et al.. (2020). An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance. ACS Applied Materials & Interfaces. 12(43). 48259–48271. 38 indexed citations
11.
Xu, Cong‐Fei, Guojun Chen, Ying‐Li Luo, et al.. (2019). Rational designs of in vivo CRISPR-Cas delivery systems. Advanced Drug Delivery Reviews. 168. 3–29. 151 indexed citations
12.
Zhang, Yue, Song Shen, Gui Zhao, et al.. (2019). In situ repurposing of dendritic cells with CRISPR/Cas9-based nanomedicine to induce transplant tolerance. Biomaterials. 217. 119302–119302. 77 indexed citations
13.
Wang, Xinglong, Xue-Song Wu, Jiating He, et al.. (2018). Synthesis of Substrate-Bound Au Nanowires Via an Active Surface Growth Mechanism. Journal of Visualized Experiments. 1 indexed citations
15.
Ji, Changqing, Shuai Tao, Junfeng Wu, et al.. (2016). Inverted Voronoi-Based kNN Query Processing with MapReduce. 2263–2268. 4 indexed citations
16.
Zuo, Zu-Qi, Kaige Chen, Xiaoyuan Yu, et al.. (2015). Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition. Biomaterials. 82. 48–59. 103 indexed citations
17.
Wu, Qiuli, Yunli Zhao, Gui Zhao, & Dayong Wang. (2014). microRNAs control of in vivo toxicity from graphene oxide in Caenorhabditis elegans. Nanomedicine Nanotechnology Biology and Medicine. 10(7). 1401–1410. 53 indexed citations
18.
Zhao, Gui, et al.. (2013). Synthesis of Polystyrene Template and Its Inverse Structure. Asian Journal of Chemistry. 25(8). 4498–4500. 1 indexed citations
19.
Zhao, Gui, et al.. (2013). Silver Mirror Reaction with Polystyrene Nanoparticles Template. Asian Journal of Chemistry. 25(8). 4467–4469. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026